Brought to you by 
Ipsen grosses €324mm in IPO
05 Jan 2006
Executive Summary
French pharmaceutical giant Ipsen completed its initial public offering on the Euronext market, selling 14.6mm shares priced at €22.20 each for gross proceeds of €324mm ($379.8mm). The company had originally priced the shares between €21.70-25.20 each.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com